Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRVL vs GSK✓SelectedUSD · GSKMRVL vs GSK performance historyLatest closeAs of-11.69%11/20
Stock and ETF performance explorer

MRVL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+59.7%
GSK return
+6.1%
Excess return
+53.6%
Maximum drawdown
-61.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-11.7%-0.1%-11.6%-11.7%
7D-22.0%-5.3%-16.7%-23.2%
30D-50.0%-3.7%-46.4%-50.4%
3M-51.3%-7.3%-44.0%-51.4%
6M-34.5%-4.2%-30.3%-34.7%
YTD+44.1%+0.9%+43.3%+42.2%
1Y+59.7%+7.3%+52.5%+49.9%
All+59.7%+6.1%+53.6%+49.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling